Antares Pharma Reports First Quarter 2018 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- Nasdaq futures lead Wall St higher as Middle East tensions ease
- Tech funds suffer record outflows as investors trim equity positions
- New leader board: Citi refreshes AI compute semiconductor picks
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
Antares Pharma (ATRS) Misses Q1 EPS by 1c
May 8, 2018 7:08 AM EDTAntares Pharma (NASDAQ: ATRS) reported Q1 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $12.7 million versus the consensus estimate of $13.3 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
... More